Published by Josh White on 21st August 2020
(Sharecast News) - Proton cancer treatment developer Advanced Oncotherapy has drawn down an initial $10m (£7.65m) from the interest-bearing secured convertible facility with Nerano Pharma, it announced on Friday.
URL: http://www.digitallook.com/dl/news/story/31087141/...